FLGT
Fulgent Genetics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$20.10
+1.46%Oct 15, 2026, 20:05 UTC
Fulgent Genetics announced that management will host an investment-community conference call to discuss the third-quarter 2026 results.
Source:Oct 15, 2026, 20:05 UTC
Fulgent Genetics announced that it will release its third-quarter 2026 financial results after the market closes on November 5, 2026.
Source:Jul 30, 2026, 23:00 UTC
Fulgent Genetics, Inc. reported a quarterly loss of $0.58 per share for Q2 2026, missing the Zacks Consensus Estimate of a loss of $0.46 per share, compared to earnings of $0.07 per share a year ago.
Source: